nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A2—Cladribine—multiple sclerosis	0.252	0.336	CbGbCtD
Diphenhydramine—SLC22A1—Cladribine—multiple sclerosis	0.219	0.292	CbGbCtD
Diphenhydramine—CYP2D6—Fingolimod—multiple sclerosis	0.0983	0.131	CbGbCtD
Diphenhydramine—CYP2C19—Prednisone—multiple sclerosis	0.0505	0.0671	CbGbCtD
Diphenhydramine—CYP2B6—Dexamethasone—multiple sclerosis	0.0496	0.0659	CbGbCtD
Diphenhydramine—CYP2C19—Dexamethasone—multiple sclerosis	0.0315	0.0419	CbGbCtD
Diphenhydramine—CYP2C9—Dexamethasone—multiple sclerosis	0.0262	0.0348	CbGbCtD
Diphenhydramine—CYP2D6—Dexamethasone—multiple sclerosis	0.0239	0.0319	CbGbCtD
Diphenhydramine—Palpitations—Fingolimod—multiple sclerosis	0.00194	0.0123	CcSEcCtD
Diphenhydramine—Neuritis—Triamcinolone—multiple sclerosis	0.00189	0.0119	CcSEcCtD
Diphenhydramine—Neuritis—Methylprednisolone—multiple sclerosis	0.00188	0.0119	CcSEcCtD
Diphenhydramine—Sweating increased—Cladribine—multiple sclerosis	0.00174	0.011	CcSEcCtD
Diphenhydramine—Neuritis—Dexamethasone—multiple sclerosis	0.00171	0.0108	CcSEcCtD
Diphenhydramine—Neuritis—Betamethasone—multiple sclerosis	0.00171	0.0108	CcSEcCtD
Diphenhydramine—Hypotension—Fingolimod—multiple sclerosis	0.00167	0.0106	CcSEcCtD
Diphenhydramine—Paraesthesia—Fingolimod—multiple sclerosis	0.00161	0.0102	CcSEcCtD
Diphenhydramine—Fatigue—Fingolimod—multiple sclerosis	0.00154	0.00975	CcSEcCtD
Diphenhydramine—Neuritis—Prednisone—multiple sclerosis	0.00149	0.00944	CcSEcCtD
Diphenhydramine—Wheezing—Triamcinolone—multiple sclerosis	0.00137	0.00866	CcSEcCtD
Diphenhydramine—Euphoric mood—Prednisolone—multiple sclerosis	0.00132	0.00833	CcSEcCtD
Diphenhydramine—Asthenia—Fingolimod—multiple sclerosis	0.00128	0.00812	CcSEcCtD
Diphenhydramine—Chills—Cladribine—multiple sclerosis	0.00128	0.0081	CcSEcCtD
Diphenhydramine—Diarrhoea—Fingolimod—multiple sclerosis	0.00122	0.00774	CcSEcCtD
Diphenhydramine—Euphoric mood—Triamcinolone—multiple sclerosis	0.00121	0.00766	CcSEcCtD
Diphenhydramine—Euphoric mood—Methylprednisolone—multiple sclerosis	0.00121	0.00764	CcSEcCtD
Diphenhydramine—Agranulocytosis—Azathioprine—multiple sclerosis	0.00121	0.00763	CcSEcCtD
Diphenhydramine—Dizziness—Fingolimod—multiple sclerosis	0.00118	0.00748	CcSEcCtD
Diphenhydramine—Sweating increased—Mitoxantrone—multiple sclerosis	0.00114	0.00722	CcSEcCtD
Diphenhydramine—Headache—Fingolimod—multiple sclerosis	0.00112	0.00709	CcSEcCtD
Diphenhydramine—Euphoric mood—Dexamethasone—multiple sclerosis	0.0011	0.00695	CcSEcCtD
Diphenhydramine—Euphoric mood—Betamethasone—multiple sclerosis	0.0011	0.00695	CcSEcCtD
Diphenhydramine—Drowsiness—Mitoxantrone—multiple sclerosis	0.00104	0.00661	CcSEcCtD
Diphenhydramine—Chills—Azathioprine—multiple sclerosis	0.00104	0.00659	CcSEcCtD
Diphenhydramine—Confusional state—Cladribine—multiple sclerosis	0.00102	0.00647	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000992	0.00628	CcSEcCtD
Diphenhydramine—Tachycardia—Cladribine—multiple sclerosis	0.000989	0.00626	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00098	0.0062	CcSEcCtD
Diphenhydramine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000975	0.00617	CcSEcCtD
Diphenhydramine—Irritability—Methylprednisolone—multiple sclerosis	0.000974	0.00616	CcSEcCtD
Diphenhydramine—Anorexia—Cladribine—multiple sclerosis	0.000966	0.00611	CcSEcCtD
Diphenhydramine—Euphoric mood—Prednisone—multiple sclerosis	0.000956	0.00605	CcSEcCtD
Diphenhydramine—Hypotension—Cladribine—multiple sclerosis	0.000947	0.00599	CcSEcCtD
Diphenhydramine—Sweating increased—Prednisolone—multiple sclerosis	0.000936	0.00592	CcSEcCtD
Diphenhydramine—Insomnia—Cladribine—multiple sclerosis	0.000917	0.0058	CcSEcCtD
Diphenhydramine—Paraesthesia—Cladribine—multiple sclerosis	0.00091	0.00576	CcSEcCtD
Diphenhydramine—Somnolence—Cladribine—multiple sclerosis	0.000901	0.0057	CcSEcCtD
Diphenhydramine—Irritability—Betamethasone—multiple sclerosis	0.000885	0.0056	CcSEcCtD
Diphenhydramine—Irritability—Dexamethasone—multiple sclerosis	0.000885	0.0056	CcSEcCtD
Diphenhydramine—Decreased appetite—Cladribine—multiple sclerosis	0.000881	0.00558	CcSEcCtD
Diphenhydramine—Fatigue—Cladribine—multiple sclerosis	0.000874	0.00553	CcSEcCtD
Diphenhydramine—Constipation—Cladribine—multiple sclerosis	0.000867	0.00548	CcSEcCtD
Diphenhydramine—Sweating increased—Triamcinolone—multiple sclerosis	0.000861	0.00545	CcSEcCtD
Diphenhydramine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000859	0.00544	CcSEcCtD
Diphenhydramine—Chills—Mitoxantrone—multiple sclerosis	0.000841	0.00532	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00084	0.00532	CcSEcCtD
Diphenhydramine—Feeling abnormal—Cladribine—multiple sclerosis	0.000835	0.00529	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000807	0.00511	CcSEcCtD
Diphenhydramine—Urticaria—Cladribine—multiple sclerosis	0.000805	0.0051	CcSEcCtD
Diphenhydramine—Sweating increased—Betamethasone—multiple sclerosis	0.000781	0.00494	CcSEcCtD
Diphenhydramine—Sweating increased—Dexamethasone—multiple sclerosis	0.000781	0.00494	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000772	0.00489	CcSEcCtD
Diphenhydramine—Irritability—Prednisone—multiple sclerosis	0.000771	0.00488	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000771	0.00488	CcSEcCtD
Diphenhydramine—Hypotension—Azathioprine—multiple sclerosis	0.00077	0.00487	CcSEcCtD
Diphenhydramine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000769	0.00487	CcSEcCtD
Diphenhydramine—Photosensitivity—Methotrexate—multiple sclerosis	0.000769	0.00487	CcSEcCtD
Diphenhydramine—Asthenia—Cladribine—multiple sclerosis	0.000727	0.0046	CcSEcCtD
Diphenhydramine—Convulsion—Mitoxantrone—multiple sclerosis	0.000707	0.00448	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000701	0.00444	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000701	0.00444	CcSEcCtD
Diphenhydramine—Diarrhoea—Cladribine—multiple sclerosis	0.000693	0.00439	CcSEcCtD
Diphenhydramine—Sweating increased—Prednisone—multiple sclerosis	0.00068	0.00431	CcSEcCtD
Diphenhydramine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000679	0.0043	CcSEcCtD
Diphenhydramine—Confusional state—Mitoxantrone—multiple sclerosis	0.000672	0.00425	CcSEcCtD
Diphenhydramine—Dizziness—Cladribine—multiple sclerosis	0.00067	0.00424	CcSEcCtD
Diphenhydramine—Cyclopentolate—BCHE—multiple sclerosis	0.00067	0.489	CrCbGaD
Diphenhydramine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000652	0.00413	CcSEcCtD
Diphenhydramine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00065	0.00411	CcSEcCtD
Diphenhydramine—Irritability—Methotrexate—multiple sclerosis	0.000644	0.00408	CcSEcCtD
Diphenhydramine—Vomiting—Cladribine—multiple sclerosis	0.000644	0.00408	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000644	0.00408	CcSEcCtD
Diphenhydramine—Rash—Cladribine—multiple sclerosis	0.000639	0.00404	CcSEcCtD
Diphenhydramine—Dermatitis—Cladribine—multiple sclerosis	0.000638	0.00404	CcSEcCtD
Diphenhydramine—Anorexia—Mitoxantrone—multiple sclerosis	0.000635	0.00402	CcSEcCtD
Diphenhydramine—Headache—Cladribine—multiple sclerosis	0.000635	0.00402	CcSEcCtD
Diphenhydramine—Vision blurred—Prednisolone—multiple sclerosis	0.000631	0.00399	CcSEcCtD
Diphenhydramine—Hypotension—Mitoxantrone—multiple sclerosis	0.000622	0.00394	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00061	0.00386	CcSEcCtD
Diphenhydramine—Nausea—Cladribine—multiple sclerosis	0.000602	0.00381	CcSEcCtD
Diphenhydramine—Vertigo—Prednisolone—multiple sclerosis	0.000602	0.00381	CcSEcCtD
Diphenhydramine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000598	0.00379	CcSEcCtD
Diphenhydramine—Somnolence—Mitoxantrone—multiple sclerosis	0.000592	0.00375	CcSEcCtD
Diphenhydramine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000586	0.00371	CcSEcCtD
Diphenhydramine—Convulsion—Prednisolone—multiple sclerosis	0.00058	0.00367	CcSEcCtD
Diphenhydramine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000579	0.00366	CcSEcCtD
Diphenhydramine—Fatigue—Mitoxantrone—multiple sclerosis	0.000574	0.00363	CcSEcCtD
Diphenhydramine—Constipation—Mitoxantrone—multiple sclerosis	0.00057	0.0036	CcSEcCtD
Diphenhydramine—Diarrhoea—Azathioprine—multiple sclerosis	0.000564	0.00357	CcSEcCtD
Diphenhydramine—Vertigo—Triamcinolone—multiple sclerosis	0.000553	0.0035	CcSEcCtD
Diphenhydramine—Vertigo—Methylprednisolone—multiple sclerosis	0.000552	0.00349	CcSEcCtD
Diphenhydramine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000549	0.00347	CcSEcCtD
Diphenhydramine—Dysuria—Methotrexate—multiple sclerosis	0.000546	0.00345	CcSEcCtD
Diphenhydramine—Dizziness—Azathioprine—multiple sclerosis	0.000545	0.00345	CcSEcCtD
Diphenhydramine—Convulsion—Triamcinolone—multiple sclerosis	0.000533	0.00338	CcSEcCtD
Diphenhydramine—Tachycardia—Prednisolone—multiple sclerosis	0.000533	0.00338	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000533	0.00337	CcSEcCtD
Diphenhydramine—Convulsion—Methylprednisolone—multiple sclerosis	0.000532	0.00337	CcSEcCtD
Diphenhydramine—Urticaria—Mitoxantrone—multiple sclerosis	0.000529	0.00335	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000528	0.00334	CcSEcCtD
Diphenhydramine—Vomiting—Azathioprine—multiple sclerosis	0.000524	0.00332	CcSEcCtD
Diphenhydramine—Drowsiness—Methotrexate—multiple sclerosis	0.00052	0.00329	CcSEcCtD
Diphenhydramine—Rash—Azathioprine—multiple sclerosis	0.00052	0.00329	CcSEcCtD
Diphenhydramine—Dermatitis—Azathioprine—multiple sclerosis	0.000519	0.00328	CcSEcCtD
Diphenhydramine—Headache—Azathioprine—multiple sclerosis	0.000516	0.00327	CcSEcCtD
Diphenhydramine—Dry mouth—Triamcinolone—multiple sclerosis	0.000513	0.00324	CcSEcCtD
Diphenhydramine—Confusional state—Methylprednisolone—multiple sclerosis	0.000506	0.0032	CcSEcCtD
Diphenhydramine—Vertigo—Dexamethasone—multiple sclerosis	0.000502	0.00318	CcSEcCtD
Diphenhydramine—Vertigo—Betamethasone—multiple sclerosis	0.000502	0.00318	CcSEcCtD
Diphenhydramine—Insomnia—Prednisolone—multiple sclerosis	0.000494	0.00313	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisolone—multiple sclerosis	0.000491	0.00311	CcSEcCtD
Diphenhydramine—Tachycardia—Triamcinolone—multiple sclerosis	0.00049	0.0031	CcSEcCtD
Diphenhydramine—Nausea—Azathioprine—multiple sclerosis	0.000489	0.0031	CcSEcCtD
Diphenhydramine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000489	0.0031	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000486	0.00307	CcSEcCtD
Diphenhydramine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000486	0.00307	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000485	0.00307	CcSEcCtD
Diphenhydramine—Convulsion—Dexamethasone—multiple sclerosis	0.000484	0.00306	CcSEcCtD
Diphenhydramine—Convulsion—Betamethasone—multiple sclerosis	0.000484	0.00306	CcSEcCtD
Diphenhydramine—Asthenia—Mitoxantrone—multiple sclerosis	0.000478	0.00302	CcSEcCtD
Diphenhydramine—Hypotension—Methylprednisolone—multiple sclerosis	0.000469	0.00297	CcSEcCtD
Diphenhydramine—Vision blurred—Prednisone—multiple sclerosis	0.000459	0.0029	CcSEcCtD
Diphenhydramine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000456	0.00288	CcSEcCtD
Diphenhydramine—Insomnia—Triamcinolone—multiple sclerosis	0.000455	0.00288	CcSEcCtD
Diphenhydramine—Insomnia—Methylprednisolone—multiple sclerosis	0.000453	0.00287	CcSEcCtD
Diphenhydramine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000451	0.00286	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00045	0.00285	CcSEcCtD
Diphenhydramine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00045	0.00285	CcSEcCtD
Diphenhydramine—Agitation—Prednisone—multiple sclerosis	0.000447	0.00283	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000446	0.00283	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000446	0.00283	CcSEcCtD
Diphenhydramine—Tachycardia—Betamethasone—multiple sclerosis	0.000445	0.00282	CcSEcCtD
Diphenhydramine—Tachycardia—Dexamethasone—multiple sclerosis	0.000445	0.00282	CcSEcCtD
Diphenhydramine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000442	0.0028	CcSEcCtD
Diphenhydramine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000441	0.00279	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000441	0.00279	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000441	0.00279	CcSEcCtD
Diphenhydramine—Vertigo—Prednisone—multiple sclerosis	0.000437	0.00277	CcSEcCtD
Diphenhydramine—Tinnitus—Methotrexate—multiple sclerosis	0.000436	0.00276	CcSEcCtD
Diphenhydramine—Anorexia—Dexamethasone—multiple sclerosis	0.000435	0.00275	CcSEcCtD
Diphenhydramine—Anorexia—Betamethasone—multiple sclerosis	0.000435	0.00275	CcSEcCtD
Diphenhydramine—Urticaria—Prednisolone—multiple sclerosis	0.000434	0.00275	CcSEcCtD
Diphenhydramine—Fatigue—Triamcinolone—multiple sclerosis	0.000433	0.00274	CcSEcCtD
Diphenhydramine—Fatigue—Methylprednisolone—multiple sclerosis	0.000432	0.00274	CcSEcCtD
Diphenhydramine—Hypotension—Betamethasone—multiple sclerosis	0.000426	0.0027	CcSEcCtD
Diphenhydramine—Hypotension—Dexamethasone—multiple sclerosis	0.000426	0.0027	CcSEcCtD
Diphenhydramine—Vomiting—Mitoxantrone—multiple sclerosis	0.000423	0.00268	CcSEcCtD
Diphenhydramine—Convulsion—Prednisone—multiple sclerosis	0.000422	0.00267	CcSEcCtD
Diphenhydramine—Rash—Mitoxantrone—multiple sclerosis	0.00042	0.00266	CcSEcCtD
Diphenhydramine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00042	0.00266	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—multiple sclerosis	0.000419	0.00265	CcSEcCtD
Diphenhydramine—Headache—Mitoxantrone—multiple sclerosis	0.000417	0.00264	CcSEcCtD
Diphenhydramine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000414	0.00262	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000413	0.00262	CcSEcCtD
Diphenhydramine—Insomnia—Betamethasone—multiple sclerosis	0.000412	0.00261	CcSEcCtD
Diphenhydramine—Insomnia—Dexamethasone—multiple sclerosis	0.000412	0.00261	CcSEcCtD
Diphenhydramine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000409	0.00259	CcSEcCtD
Diphenhydramine—Paraesthesia—Betamethasone—multiple sclerosis	0.000409	0.00259	CcSEcCtD
Diphenhydramine—Dyspepsia—Betamethasone—multiple sclerosis	0.000401	0.00254	CcSEcCtD
Diphenhydramine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000401	0.00254	CcSEcCtD
Diphenhydramine—Urticaria—Triamcinolone—multiple sclerosis	0.000399	0.00253	CcSEcCtD
Diphenhydramine—Urticaria—Methylprednisolone—multiple sclerosis	0.000398	0.00252	CcSEcCtD
Diphenhydramine—Decreased appetite—Betamethasone—multiple sclerosis	0.000396	0.00251	CcSEcCtD
Diphenhydramine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000396	0.00251	CcSEcCtD
Diphenhydramine—Nausea—Mitoxantrone—multiple sclerosis	0.000396	0.0025	CcSEcCtD
Diphenhydramine—Fatigue—Betamethasone—multiple sclerosis	0.000393	0.00249	CcSEcCtD
Diphenhydramine—Fatigue—Dexamethasone—multiple sclerosis	0.000393	0.00249	CcSEcCtD
Diphenhydramine—Tachycardia—Prednisone—multiple sclerosis	0.000388	0.00245	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000384	0.00243	CcSEcCtD
Diphenhydramine—Vision blurred—Methotrexate—multiple sclerosis	0.000383	0.00243	CcSEcCtD
Diphenhydramine—Anorexia—Prednisone—multiple sclerosis	0.000379	0.0024	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000376	0.00238	CcSEcCtD
Diphenhydramine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000376	0.00238	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—multiple sclerosis	0.000365	0.00231	CcSEcCtD
Diphenhydramine—Urticaria—Betamethasone—multiple sclerosis	0.000362	0.00229	CcSEcCtD
Diphenhydramine—Urticaria—Dexamethasone—multiple sclerosis	0.000362	0.00229	CcSEcCtD
Diphenhydramine—Dizziness—Prednisolone—multiple sclerosis	0.000361	0.00229	CcSEcCtD
Diphenhydramine—Asthenia—Triamcinolone—multiple sclerosis	0.000361	0.00228	CcSEcCtD
Diphenhydramine—Asthenia—Methylprednisolone—multiple sclerosis	0.00036	0.00228	CcSEcCtD
Diphenhydramine—Insomnia—Prednisone—multiple sclerosis	0.000359	0.00227	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisone—multiple sclerosis	0.000357	0.00226	CcSEcCtD
Diphenhydramine—Convulsion—Methotrexate—multiple sclerosis	0.000352	0.00223	CcSEcCtD
Diphenhydramine—Dyspepsia—Prednisone—multiple sclerosis	0.00035	0.00221	CcSEcCtD
Diphenhydramine—Decreased appetite—Prednisone—multiple sclerosis	0.000345	0.00218	CcSEcCtD
Diphenhydramine—Rash—Prednisolone—multiple sclerosis	0.000345	0.00218	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisolone—multiple sclerosis	0.000344	0.00218	CcSEcCtD
Diphenhydramine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000343	0.00217	CcSEcCtD
Diphenhydramine—Fatigue—Prednisone—multiple sclerosis	0.000342	0.00217	CcSEcCtD
Diphenhydramine—Headache—Prednisolone—multiple sclerosis	0.000342	0.00217	CcSEcCtD
Diphenhydramine—Constipation—Prednisone—multiple sclerosis	0.00034	0.00215	CcSEcCtD
Diphenhydramine—Confusional state—Methotrexate—multiple sclerosis	0.000335	0.00212	CcSEcCtD
Diphenhydramine—Dizziness—Triamcinolone—multiple sclerosis	0.000332	0.0021	CcSEcCtD
Diphenhydramine—Dizziness—Methylprednisolone—multiple sclerosis	0.000332	0.0021	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisone—multiple sclerosis	0.000327	0.00207	CcSEcCtD
Diphenhydramine—Asthenia—Betamethasone—multiple sclerosis	0.000327	0.00207	CcSEcCtD
Diphenhydramine—Asthenia—Dexamethasone—multiple sclerosis	0.000327	0.00207	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000325	0.00206	CcSEcCtD
Diphenhydramine—Nausea—Prednisolone—multiple sclerosis	0.000325	0.00205	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000321	0.00203	CcSEcCtD
Diphenhydramine—Vomiting—Triamcinolone—multiple sclerosis	0.00032	0.00202	CcSEcCtD
Diphenhydramine—Vomiting—Methylprednisolone—multiple sclerosis	0.000319	0.00202	CcSEcCtD
Diphenhydramine—Rash—Triamcinolone—multiple sclerosis	0.000317	0.00201	CcSEcCtD
Diphenhydramine—Dermatitis—Triamcinolone—multiple sclerosis	0.000317	0.002	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—multiple sclerosis	0.000316	0.002	CcSEcCtD
Diphenhydramine—Rash—Methylprednisolone—multiple sclerosis	0.000316	0.002	CcSEcCtD
Diphenhydramine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000316	0.002	CcSEcCtD
Diphenhydramine—Urticaria—Prednisone—multiple sclerosis	0.000315	0.002	CcSEcCtD
Diphenhydramine—Headache—Triamcinolone—multiple sclerosis	0.000315	0.00199	CcSEcCtD
Diphenhydramine—Headache—Methylprednisolone—multiple sclerosis	0.000314	0.00199	CcSEcCtD
Diphenhydramine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000312	0.00197	CcSEcCtD
Diphenhydramine—Diarrhoea—Betamethasone—multiple sclerosis	0.000312	0.00197	CcSEcCtD
Diphenhydramine—Hypotension—Methotrexate—multiple sclerosis	0.00031	0.00196	CcSEcCtD
Diphenhydramine—Dizziness—Betamethasone—multiple sclerosis	0.000302	0.00191	CcSEcCtD
Diphenhydramine—Dizziness—Dexamethasone—multiple sclerosis	0.000302	0.00191	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—multiple sclerosis	0.0003	0.0019	CcSEcCtD
Diphenhydramine—Nausea—Triamcinolone—multiple sclerosis	0.000298	0.00189	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—multiple sclerosis	0.000298	0.00189	CcSEcCtD
Diphenhydramine—Nausea—Methylprednisolone—multiple sclerosis	0.000298	0.00188	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—multiple sclerosis	0.000295	0.00187	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—multiple sclerosis	0.000292	0.00185	CcSEcCtD
Diphenhydramine—Vomiting—Dexamethasone—multiple sclerosis	0.00029	0.00183	CcSEcCtD
Diphenhydramine—Vomiting—Betamethasone—multiple sclerosis	0.00029	0.00183	CcSEcCtD
Diphenhydramine—Decreased appetite—Methotrexate—multiple sclerosis	0.000288	0.00183	CcSEcCtD
Diphenhydramine—Rash—Dexamethasone—multiple sclerosis	0.000287	0.00182	CcSEcCtD
Diphenhydramine—Rash—Betamethasone—multiple sclerosis	0.000287	0.00182	CcSEcCtD
Diphenhydramine—Dermatitis—Dexamethasone—multiple sclerosis	0.000287	0.00182	CcSEcCtD
Diphenhydramine—Dermatitis—Betamethasone—multiple sclerosis	0.000287	0.00182	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—multiple sclerosis	0.000286	0.00181	CcSEcCtD
Diphenhydramine—Headache—Dexamethasone—multiple sclerosis	0.000286	0.00181	CcSEcCtD
Diphenhydramine—Headache—Betamethasone—multiple sclerosis	0.000286	0.00181	CcSEcCtD
Diphenhydramine—Asthenia—Prednisone—multiple sclerosis	0.000285	0.0018	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000273	0.00173	CcSEcCtD
Diphenhydramine—Diarrhoea—Prednisone—multiple sclerosis	0.000272	0.00172	CcSEcCtD
Diphenhydramine—Nausea—Dexamethasone—multiple sclerosis	0.000271	0.00171	CcSEcCtD
Diphenhydramine—Nausea—Betamethasone—multiple sclerosis	0.000271	0.00171	CcSEcCtD
Diphenhydramine—Urticaria—Methotrexate—multiple sclerosis	0.000264	0.00167	CcSEcCtD
Diphenhydramine—Dizziness—Prednisone—multiple sclerosis	0.000263	0.00166	CcSEcCtD
Diphenhydramine—Vomiting—Prednisone—multiple sclerosis	0.000252	0.0016	CcSEcCtD
Diphenhydramine—Rash—Prednisone—multiple sclerosis	0.00025	0.00158	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisone—multiple sclerosis	0.00025	0.00158	CcSEcCtD
Diphenhydramine—Headache—Prednisone—multiple sclerosis	0.000249	0.00157	CcSEcCtD
Diphenhydramine—Asthenia—Methotrexate—multiple sclerosis	0.000238	0.00151	CcSEcCtD
Diphenhydramine—Nausea—Prednisone—multiple sclerosis	0.000236	0.00149	CcSEcCtD
Diphenhydramine—Diarrhoea—Methotrexate—multiple sclerosis	0.000227	0.00144	CcSEcCtD
Diphenhydramine—Dizziness—Methotrexate—multiple sclerosis	0.000219	0.00139	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—multiple sclerosis	0.000211	0.00134	CcSEcCtD
Diphenhydramine—Rash—Methotrexate—multiple sclerosis	0.000209	0.00132	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—multiple sclerosis	0.000209	0.00132	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—multiple sclerosis	0.000208	0.00132	CcSEcCtD
Diphenhydramine—Fenoprofen—ALB—multiple sclerosis	0.000199	0.146	CrCbGaD
Diphenhydramine—Nausea—Methotrexate—multiple sclerosis	0.000197	0.00125	CcSEcCtD
Diphenhydramine—Phenprocoumon—ALB—multiple sclerosis	0.000172	0.126	CrCbGaD
Diphenhydramine—Warfarin—ALB—multiple sclerosis	0.000153	0.111	CrCbGaD
Diphenhydramine—Phenytoin—ALB—multiple sclerosis	0.000111	0.0809	CrCbGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	7.37e-05	0.00083	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	7.28e-05	0.00082	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	7.28e-05	0.00082	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	7.25e-05	0.000816	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	7.25e-05	0.000816	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.24e-05	0.000816	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	7.23e-05	0.000814	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	7.16e-05	0.000807	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	7.16e-05	0.000807	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	7.11e-05	0.000801	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GPC5—multiple sclerosis	7.11e-05	0.000801	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	7.02e-05	0.000791	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	7e-05	0.000788	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	6.99e-05	0.000787	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.91e-05	0.000778	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GPC5—multiple sclerosis	6.9e-05	0.000777	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.9e-05	0.000777	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.9e-05	0.000777	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	6.9e-05	0.000777	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	6.88e-05	0.000774	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	6.79e-05	0.000765	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	6.79e-05	0.000764	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.7e-05	0.000754	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GPC5—multiple sclerosis	6.63e-05	0.000746	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	6.61e-05	0.000744	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	6.61e-05	0.000744	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	6.59e-05	0.000742	CbGpPWpGaD
Diphenhydramine—Amitriptyline—ALB—multiple sclerosis	6.52e-05	0.0476	CrCbGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	6.5e-05	0.000732	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	6.5e-05	0.000732	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.24e-05	0.000703	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SRM—multiple sclerosis	6.18e-05	0.000696	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	6.06e-05	0.000682	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	5.96e-05	0.000671	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	5.94e-05	0.000669	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—RRM1—multiple sclerosis	5.89e-05	0.000664	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	5.84e-05	0.000658	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.76e-05	0.000648	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.76e-05	0.000648	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.72e-05	0.000645	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—RRM1—multiple sclerosis	5.72e-05	0.000644	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SRM—multiple sclerosis	5.68e-05	0.00064	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SRM—multiple sclerosis	5.63e-05	0.000634	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	5.53e-05	0.000623	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—RRM1—multiple sclerosis	5.49e-05	0.000618	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.49e-05	0.000618	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.41e-05	0.000609	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.4e-05	0.000608	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.37e-05	0.000605	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	5.35e-05	0.000602	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	5.3e-05	0.000596	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.28e-05	0.000595	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPC5—multiple sclerosis	5.27e-05	0.000593	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.26e-05	0.000593	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	5.26e-05	0.000593	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	5.22e-05	0.000588	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	5.21e-05	0.000587	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	5.15e-05	0.00058	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.13e-05	0.000577	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—BCHE—multiple sclerosis	5.1e-05	0.000574	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.08e-05	0.000572	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	5.07e-05	0.000571	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	4.99e-05	0.000562	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	4.91e-05	0.000553	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.82e-05	0.000543	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SRM—multiple sclerosis	4.81e-05	0.000542	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.78e-05	0.000538	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.74e-05	0.000534	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	4.71e-05	0.00053	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	4.69e-05	0.000528	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	4.63e-05	0.000522	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	4.62e-05	0.00052	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	4.53e-05	0.000511	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	4.5e-05	0.000507	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	4.46e-05	0.000502	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.46e-05	0.000502	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.44e-05	0.0005	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	4.43e-05	0.000499	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	4.38e-05	0.000493	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.36e-05	0.000491	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.35e-05	0.00049	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.35e-05	0.00049	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	4.33e-05	0.000487	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	4.31e-05	0.000485	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	4.27e-05	0.000481	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	4.26e-05	0.00048	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	4.26e-05	0.00048	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.25e-05	0.000479	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	4.2e-05	0.000473	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.19e-05	0.000472	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	4.19e-05	0.000472	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	4.18e-05	0.000471	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	4.11e-05	0.000463	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.1e-05	0.000461	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	4.09e-05	0.000461	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	4.02e-05	0.000453	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4e-05	0.000451	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4e-05	0.000451	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.98e-05	0.000448	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.97e-05	0.000447	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.97e-05	0.000447	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	3.93e-05	0.000443	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	3.93e-05	0.000442	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	3.9e-05	0.00044	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	3.9e-05	0.00044	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.9e-05	0.000439	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.88e-05	0.000437	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	3.87e-05	0.000436	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	3.84e-05	0.000433	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	3.84e-05	0.000433	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.83e-05	0.000432	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.81e-05	0.000429	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	3.66e-05	0.000412	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.66e-05	0.000412	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.63e-05	0.000409	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	3.54e-05	0.000399	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	3.48e-05	0.000392	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.48e-05	0.000391	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.4e-05	0.000383	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.39e-05	0.000382	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.39e-05	0.000382	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—BCHE—multiple sclerosis	3.38e-05	0.000381	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	3.35e-05	0.000378	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.31e-05	0.000373	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	3.3e-05	0.000372	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.3e-05	0.000371	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—BCHE—multiple sclerosis	3.29e-05	0.00037	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.22e-05	0.000363	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.17e-05	0.000357	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—BCHE—multiple sclerosis	3.15e-05	0.000355	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.1e-05	0.000349	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—APOE—multiple sclerosis	3.07e-05	0.000345	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	3.05e-05	0.000343	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.03e-05	0.000342	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	3.02e-05	0.00034	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.01e-05	0.000339	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	3e-05	0.000338	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.98e-05	0.000335	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	2.97e-05	0.000335	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.93e-05	0.00033	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	2.78e-05	0.000313	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	2.74e-05	0.000309	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	2.74e-05	0.000308	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	2.71e-05	0.000305	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	2.7e-05	0.000304	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	2.68e-05	0.000302	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	2.66e-05	0.0003	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PGR—multiple sclerosis	2.64e-05	0.000297	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	2.64e-05	0.000297	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—POMC—multiple sclerosis	2.63e-05	0.000297	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	2.6e-05	0.000292	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	2.59e-05	0.000291	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.57e-05	0.000289	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CD28—multiple sclerosis	2.56e-05	0.000289	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.56e-05	0.000288	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	2.55e-05	0.000287	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	2.52e-05	0.000284	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	2.52e-05	0.000283	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.51e-05	0.000282	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	2.48e-05	0.000279	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ALB—multiple sclerosis	2.4e-05	0.000271	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	2.36e-05	0.000266	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.33e-05	0.000263	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.32e-05	0.000262	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	2.32e-05	0.000261	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.28e-05	0.000257	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.2e-05	0.000248	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	2.15e-05	0.000242	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.11e-05	0.000238	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	2.1e-05	0.000236	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	2.09e-05	0.000235	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.07e-05	0.000233	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.06e-05	0.000232	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOE—multiple sclerosis	2.04e-05	0.000229	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2e-05	0.000226	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2e-05	0.000226	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.99e-05	0.000225	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOE—multiple sclerosis	1.98e-05	0.000223	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.91e-05	0.000215	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOE—multiple sclerosis	1.9e-05	0.000214	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.89e-05	0.000213	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.88e-05	0.000211	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.83e-05	0.000206	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.83e-05	0.000206	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.8e-05	0.000203	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.8e-05	0.000203	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.77e-05	0.000199	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—POMC—multiple sclerosis	1.75e-05	0.000197	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.75e-05	0.000197	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.000196	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.000194	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.72e-05	0.000194	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.71e-05	0.000193	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—POMC—multiple sclerosis	1.7e-05	0.000191	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.67e-05	0.000188	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.64e-05	0.000185	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POMC—multiple sclerosis	1.63e-05	0.000184	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.62e-05	0.000183	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.6e-05	0.00018	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.6e-05	0.00018	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—multiple sclerosis	1.59e-05	0.00018	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.59e-05	0.000179	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.57e-05	0.000177	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.56e-05	0.000176	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.56e-05	0.000176	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—multiple sclerosis	1.55e-05	0.000174	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.51e-05	0.00017	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—multiple sclerosis	1.49e-05	0.000167	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.48e-05	0.000166	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.48e-05	0.000166	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.45e-05	0.000163	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	0.00015	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.31e-05	0.000148	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000146	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.27e-05	0.000143	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.25e-05	0.00014	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.24e-05	0.00014	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.22e-05	0.000137	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.19e-05	0.000134	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.18e-05	0.000133	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000128	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.13e-05	0.000127	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.11e-05	0.000125	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POMC—multiple sclerosis	9.79e-06	0.00011	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—multiple sclerosis	9.37e-06	0.000105	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	9.32e-06	0.000105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.22e-06	0.000104	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.17e-06	0.000103	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POMC—multiple sclerosis	9e-06	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POMC—multiple sclerosis	8.93e-06	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—multiple sclerosis	8.92e-06	0.000101	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOE—multiple sclerosis	8.88e-06	0.0001	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	8.87e-06	9.98e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	8.72e-06	9.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—multiple sclerosis	8.21e-06	9.24e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—multiple sclerosis	8.14e-06	9.16e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	7.88e-06	8.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	7.76e-06	8.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POMC—multiple sclerosis	7.63e-06	8.59e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—multiple sclerosis	7.33e-06	8.25e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	7.31e-06	8.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.21e-06	8.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.19e-06	8.1e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	7.17e-06	8.07e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7.05e-06	7.94e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—multiple sclerosis	6.95e-06	7.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—multiple sclerosis	5.51e-06	6.2e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.42e-06	6.1e-05	CbGpPWpGaD
